Endothelin, endothelin receptors, and endothelin antagonists

Area of Science:

• Cardiovascular Biology
• Molecular Pharmacology
• Cell Signaling

Background:

• Endothelin (ET) is a potent vasoactive peptide with diverse cellular effects.
• ET mediates its actions through ETA and ETB receptors, potentially involving ETC.
• Vascular smooth muscle and endothelial cells express these receptors, influencing tone and function.

Purpose of the Study:

• To elucidate the mechanisms of endothelin's effects on vascular and nonvascular cells.
• To detail the roles of ETA and ETB receptors in endothelin's actions.
• To explore the signaling pathways activated by endothelin.

Main Methods:

• Review of existing literature on endothelin biology and receptor pharmacology.
• Analysis of cellular and in vivo studies on endothelin's effects.
• Examination of signaling cascades, including phospholipase C and calcium channels.

Main Results:

• Endothelin induces profound vasoconstriction via ETA and ETB receptors in vascular smooth muscle.
• Endothelin can cause vasodilation through ETB receptor activation on endothelial cells, linked to nitric oxide and prostacyclin.
• Endothelin signaling involves phospholipase C, inositol triphosphate, diacylglycerol, and calcium mobilization, affecting smooth muscle contraction.
• Endothelin also activates voltage-operated calcium channels, explaining the efficacy of calcium antagonists.

Conclusions:

• Endothelin's dual effects on vascular tone are receptor- and cell-type dependent.
• The peptide's signaling pathways are complex, involving intracellular calcium and protein activation.
• Understanding endothelin's mechanisms is crucial for cardiovascular research and potential therapeutic interventions.